Metabolic Engineering enables new design chemicals
The product portfolio is too small; production is too expensive or difficult to scale up. A new field might help industrial biotechnology to achieve a breakthrough: synthetic biology, i.e. the reprograming of biological systems. Until now, the fact that new chemicals only reached commercialisation via expensive fundamental research was regarded as the bottleneck of this modern biotechnology. A challenge, which has now been taken up by the biotech start-ups, Zymergen and Arzeda. Instead of looking for suitable chemical solutions in biology, the companies manipulate the DNA of naturally occurring enzymes to manufacture the appropriate chemicals directly using fermentation.
This “metabolic engineering”, as it is known, is not carried out by people but by an automated process, which is based on Big Data, at a fraction of the current costs. Consequently metabolic engineering will open up new paths to industrial development and commercialisation of design chemicals.
Whereas only yesterday, development departments spent months researching a new chemical, in future, artificial intelligence will search for the most effective recipe in a fully automated process, which will only take a few weeks. The ultimate vision is the disruption of traditional production processes in the chemicals industry and the start of a post-petro era.
AI and sustainability: a new strategic area of activity
Responsible AI – which rules should be applied to the development of AI applications in future?
Artificial Intelligence as Inventor and Developer
New applications for AI.
Digital Cryptocurrency in Barcelona
Local currencies are proliferating.
Immersive Exosuits with Textile Muscle Fibres
The next steps towards cyborgism.
Agricultural Robotics for Efficient Indoor Farming
Vertical farming for salad heads.
Receive the regular Z_punkt newsletter in your mailbox. Sign up now.